Study of AVZO-021 in Patients With Advanced Solid Tumors

NCT05867251 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

430

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
HR+/HER2- Breast Cancer
HR+, HER2-, Advanced Breast Cancer
CCNE1 Amplification
Epithelial Ovarian Cancer
Primary Peritoneal Cancer
Fallopian Tube Cancer
Endometrial Cancer
TNBC - Triple-Negative Breast Cancer

Interventions

DRUG: AVZO-021
DRUG: Palbociclib
DRUG: Fulvestrant
DRUG: Letrozole
DRUG: Ribociclib
DRUG: Abemaciclib
DRUG: Carboplatin
DRUG: Sacituzumab Govitecan-hziy

Sponsor

Avenzo Therapeutics, Inc.